Viking Therapeutics (1VT.STU) Q1 2026 Earnings

11FebConfirmed
Q1 2026
-1.16
-1.02
-0.89
-0.75

Details

Expected EPS
-0.74965666752
Actual EPS
-1.1620704
Surprise EPS
-0.41
Surprise Percent
+55.01%

Description

Viking Therapeutics (1VT.STU) has reported earnings of -1.1620704 per share for Q1 2026.

0 Comments

Share your thoughts